文献速递肿瘤 PET/CT

多中心头颈癌队列中PET/CT影像的放射组学预后分析:探究ComBat策略、亚体积表征与自动分割

Radiomics prognostic analysis of PET/CT images in a multicenter head and neck cancer cohort: investigating ComBat strategies, sub-volume characterization, and automatic segmentation.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-01-24

本研究利用HECKTOR MICCAI 2021挑战赛集中325例口咽头颈癌患者的PET/CT影像与临床数据,提取346个符合IBSI的放射组学特征,采用Lasso-Cox筛选特征并构建CoxPH模型预测无进展生存期,比较8种ComBat harmonization策略、肿瘤亚体积聚类特征及3种自动分割方法。未行harmonization联合临床因素的模型测试集C-index为0.69,最佳ComBat策略(特征筛选后、按特征组分别、基于聚类标签)达0.71,联合肿瘤亚体积特征提升至0.72,自动分割模型预后性能接近但略低(0.67-0.70)。结论认为标准化放射组学流程可预测多中心头颈癌队列的PFS,特定ComBat策略可改善性能。

要点

  • 未行harmonization联合临床因素模型测试集C-index为0.69。
  • 最佳ComBat策略(特征筛选后、按特征组分别、聚类标签)C-index为0.71。
  • 联合肿瘤亚体积特征使C-index提升至0.72,自动分割模型为0.67-0.70。

核心结论

  • 标准化放射组学流程可在多中心头颈癌队列中预测无进展生存期(PFS)。
  • 应用特定ComBat harmonization策略可改善模型性能。
  • 提取肿瘤内亚体积特征和自动分割可能分别有助于改善和自动化预后建模。

研究设计与样本

  • 研究利用HECKTOR MICCAI 2021挑战赛集,包含325例口咽头颈癌患者的PET/CT影像与临床数据。
  • 对每例患者参考手动勾画的原发肿瘤体积提取346个符合IBSI的放射组学特征。
  • 采用Lasso-Cox进行特征筛选,构建CoxPH模型预测PFS。
  • 比较8种ComBat harmonization策略(特征筛选前或后、按特征组分别或全部特征直接、中心标签或聚类确定标签)。
  • 评估肿瘤亚体积聚类特征的预后附加价值,并比较3种自动分割(2种阈值法和1种3D U-Net)。

主要发现

  • 未行harmonization的放射组学特征联合临床因素,模型在测试集C-index为0.69。
  • 最佳ComBat harmonization版本为特征筛选后、按特征组分别、基于聚类确定标签,C-index达0.71。
  • 使用肿瘤亚体积提取的特征进一步将C-index提升至0.72。
  • 基于自动分割的模型预后性能接近但略低于参考轮廓,C-index为0.67-0.70。

关键数值与推荐

  • 未行harmonization联合临床因素模型测试集C-index为0.69。
  • 最佳ComBat策略(特征筛选后、按特征组分别、聚类标签)C-index为0.71。
  • 联合肿瘤亚体积特征C-index为0.72。
  • 自动分割模型C-index为0.67-0.70。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to investigate the impact of several ComBat harmonization strategies, intra-tumoral sub-volume characterization, and automatic segmentations for progression-free survival (PFS) prediction through radiomics modeling for patients with head and neck cancer (HNC) in PET/CT images. METHODS: The HECKTOR MICCAI 2021 challenge set containing PET/CT images and clinical data of 325 oropharynx HNC patients was exploited. A total of 346 IBSI-compliant radiomic features were extracted for each patient's primary tumor volume defined by the reference manual contours. Modeling relied on least absolute shrinkage Cox regression (Lasso-Cox) for feature selection (FS) and Cox proportional-hazards (CoxPH) models were built to predict PFS. Within this methodological framework, 8 different strategies for ComBat harmonization were compared, including before or after FS, in feature groups separately or all features directly, and with center or clustering-determined labels. Features extracted from tumor sub-volume clustering were also investigated for their prognostic additional value. Finally, 3 automatic segmentations (2 threshold-based and a 3D U-Net) were also compared. All results were evaluated with the concordance index (C-index). RESULTS: Radiomics features without harmonization, combined with clinical factors, led to models with C-index values of 0.69 in the testing set. The best version of ComBat harmonization, i.e., after FS, for feature groups separately and relying on clustering-determined labels, achieved a C-index of 0.71. The use of features extracted from tumor sub-volumes further improved the C-index to 0.72. Models that relied on the automatic segmentations yielded close but slightly lower prognostic performance (0.67-0.70) compared to reference contours. CONCLUSION: A standard radiomics pipeline allowed for prediction of PFS in a multicenter HNC cohort. Applying a specific strategy of ComBat harmonization improved the performance. The extraction of intra-tumoral sub-volume features and automatic segmentation could contribute to the improvement and automation of prognosis modeling, respectively.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Xu H, Abdallah N, Marion JM, et al. Radiomics prognostic analysis of PET/CT images in a multicenter head and neck cancer cohort: investigating ComBat strategies, sub-volume characterization, and automatic segmentation. Eur J Nucl Med Mol Imaging. 2023. PMID: 36690882. doi:10.1007/s00259-023-06118-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。